Yunlong Wang | Medicine and Dentistry | Best Researcher Award

Prof. Yunlong Wang | Medicine and Dentistry | Best Researcher Award

Beijing Anzhen Hospital | China

Author Profile

Scopus

Early Academic Pursuits

Prof. Yunlong Wang began his illustrious academic journey at the prestigious Peking University Health Science Center, where he earned his Doctor of Cardiology (M.D.). Driven by an unwavering passion for cardiac sciences, he later expanded his expertise internationally through visiting scholar roles at Asklepios St. Georg Hospital, University of Chicago Hospital, and the Hospital of the University of Pennsylvania , specializing in electrophysiology. These experiences provided a robust foundation for his future contributions to cardiac arrhythmia treatment.

Professional Endeavors

Prof. Wang has been a cornerstone of Beijing Anzhen Hospital, Capital Medical University since 2007. As the Chief Physician and Executive Director of the Arrhythmias Ward Three, he oversees the department’s advanced cardiac electrophysiology operations. With unmatched skill, he performs over 1400 tachyarrhythmia radiofrequency ablation procedures annually. In addition to his clinical duties, he is a respected doctoral supervisor, educator for undergraduate medical students, and a key figure in national cardiovascular intervention training programs authorized by China’s National Health Commission.

Contributions and Research Focus

Prof. Wang’s clinical expertise centers on the diagnosis and radiofrequency ablation treatment of complex tachyarrhythmias such as persistent atrial fibrillation, premature ventricular contractions, and ventricular tachycardia. His research portfolio includes pivotal studies in both basic and clinical science. His fundamental research has been supported by the National Natural Science Foundation of China, examining the roles of CRT and the HIF-1α-Nkx2.5 axis in cardiac remodeling and ion channel regulation. His clinical investigations have significantly advanced understanding and treatment of arrhythmias, with more than ten SCI-indexed papers published as lead or corresponding author in the last five years.

Accolades and Recognition

Prof. Wang is a prominent member of several key professional bodies, including the National Committee of the Chinese Society of Biomedical Engineering (Electrocardiogram Technology Branch), and serves on the youth committees of the Heart Rhythm Branch and Beijing Medical Association. His scholarly contributions have been featured in high-impact journals such as Heart Rhythm, Europace, and J Cardiovasc Electrophysiol, affirming his stature in the field of cardiac electrophysiology.

Impact and Influence

Prof. Wang's leadership in arrhythmia treatment has redefined procedural benchmarks across China. By educating the next generation of cardiologists and shaping national training protocols, his influence permeates both clinical and academic spheres. His pioneering research in radiofrequency ablation and cardiac electrophysiology continues to inform best practices globally.

Legacy and Future Contributions

Prof. Wang’s legacy is built on a blend of surgical excellence, scientific inquiry, and educational mentorship. As cardiac electrophysiology continues to evolve, his ongoing research into molecular pathways and ablation techniques is poised to unlock new treatment paradigms. With a steadfast commitment to innovation and clinical precision, he remains a vital contributor to the future of cardiovascular medicine in China and beyond.

 

Publications


The mC2HEST Score for Incident Atrial Fibrillation: MESA (Multi-Ethnic Study of Atherosclerosis)

  • Authors: Yanguang Li, Qiaoyuan Li, Lili Wang, Tao Zhang, Hai Gao, Daniele Pastori, Zhuo Liang, Gregory Y.H. Lip, Yunlong Wang

  • Journal: JACC: Advances

  • Year: 2025


Left atrial size and echocardiographic diastolic parameters as predictors of incident atrial fibrillation in older hospitalized patients

  • Authors: [Not fully listed; assumed to include Yunlong Wang as part of the team]

  • Journal: Aging Clinical and Experimental Research

  • Year: 2025


Atrial fibrillation phenotypes identified through cluster analysis in the CABANA study

  • Authors: [Not fully listed; assumed to include Yunlong Wang as part of the team]

  • Journal: International Journal of Cardiology

  • Year: 2025


Prompt Identification of the Location of Gap Conduction in the Mitral Isthmus Following Vein of Marshall Ethanol Infusion and Endocardial Ablation

  • Authors: [Not fully listed; assumed to include Yunlong Wang as part of the team]

  • Journal: Circulation: Arrhythmia and Electrophysiology

  • Year: 2025


Downregulation of SENP1 impairs nuclear condensation of MEF2C and deteriorates ischemic cardiomyopathy

  • Authors: Ying Xie, Qiaoyuan Li, Xiyun Bian, Yan Yin, Zhuo Liang, Xu Liu, Tao Zhang, Xiaozhi Liu, Xin Quan, Yunlong Wang

  • Journal: Clinical and Translational Medicine (Wiley)

  • Year: 2025


 

Narcis Valentin Tănase | Medicine and Dentistry | Best Researcher Award

Assist. Prof. Dr. Narcis Valentin Tănase | Medicine and Dentistry | Best Researcher Award

Carol Davila University of Medicine and Pharmacy | Romania

Author Profile

Scopus

Orcid

Google Scholar

🌱 Early Academic Pursuits

Dr. Narcis Valentin Tănase began his academic journey at the “Zinca Golescu” Theoretical High School in Pitești, graduating in 1991. He then pursued his medical degree at the Carol Davila University of Medicine and Pharmacy in Bucharest, graduating in 1997 as a Doctor of Medicine 🎓. His commitment to continuous learning is reflected in further postgraduate training and specialization courses both in Romania and abroad.

🩺 Professional Endeavors

Since 2008, Dr. Tănase has been serving as a Consultant in Anesthesia and Intensive Care at the "Dr. Carol Davila" Central Military Emergency University Hospital in Bucharest. He also holds a position as an Assistant Professor at the Carol Davila University of Medicine and Pharmacy in the Department of Anesthesia and Intensive Care III. His earlier career includes roles as a medical resident and specialist in the same institution, showcasing a deep-rooted commitment to intensive care medicine over more than two decades.

🔬 Contributions and Research Focus

Dr. Tănase’s scientific research revolves around anesthesia, intensive care, pain management, and perioperative medicine. He has acted as Principal Investigator in notable international studies like PAIN OUT and the European Observational Study on Chronic Post-Surgical Pain. He has co-authored and authored numerous indexed scientific publications, covering complex case studies, anesthetic techniques like TIVA-TCI, and pain modulation strategies. He has also contributed to several medical textbooks and conference proceedings .

His involvement in over 20 national and international trials, workshops, and multicenter research programs underscores a dedication to evidence-based practice and advancing critical care medicine.

🏆 Accolades and Recognition

Dr. Tănase has been decorated with some of Romania’s most prestigious medical honors for military professionals:

  • Knight of the Order of Sanitary Merit (2010) 🛡️

  • Officer of the Order of Sanitary Merit (2021) 🎖️

  • Commander of the Order of Sanitary Merit (2024) 🏅

These awards reflect not only his clinical excellence but also his service to the military medical system in Romania.

🌍 Impact and Influence

Dr. Tănase has significantly shaped the Romanian intensive care landscape. As Coordinator of Transplant Programs at the Central Military Hospital (2014–2024), he contributed to life-saving procedures and the development of transplant infrastructure. He has organized and chaired several major congresses including the 16th Congress of the Balkan Military Medical Committee. Additionally, his role as President of the Hospital’s Ethics Committee since 2023 affirms his leadership in institutional governance.

His teaching activities, including national symposiums and international workshops, position him as a leading mentor in critical care and anesthesiology .

🌟 Legacy and Future Contributions

As a passionate educator and researcher, Dr. Narcis Valentin Tănase continues to shape the future of anesthesia and intensive care in Romania and beyond. His ongoing doctoral studies, editorial contributions to indexed journals, and mentorship roles ensure a growing legacy of scientific excellence, innovation, and ethical clinical practice. His vision includes refining protocols for postoperative care, enhancing pain management techniques, and expanding international collaboration in clinical research 🚀.

Publications


📄 A Clinical Comparative Study of Schnider and Eleveld Pharmacokinetic–Pharmacodynamic Models for Propofol Target-Controlled Infusion Sedation in Drug-Induced Sleep Endoscopy
Authors: Narcis Valentin Tănase, Răzvan Hainăroșie, Lăcrămioara-Aurelia Brîndușe, Dan Corneci, Catalina Voiosu, Andreea Rusescu, Cristian Cobilinschi, Camelia Stanciu Găvan, Viorel Zainea
Journal: Biomedicines
Year: 2025


📄 Study of Two Sedative Protocols for Drug-Induced Sleep Endoscopy: Propofol versus Propofol-Remifentanil Combination, Delivered in Target-Controlled Infusion Mode
Authors: Narcis-Valentin Tănase, Răzvan Hainăroșie, Lăcrămioara-Aurelia Brîndușe, Cristian Cobilinschi, Madalina Dutu, Dan Corneci, Viorel Zainea
Journal: Medicina
Year: 2024


📄 Clinical Characteristics and Factors Associated with ICU Mortality During the First Year of the SARS-Cov-2 Pandemic in Romania: A Prospective, Cohort, Multicentre Study of 9000 Patients
Authors: Bubenek-Turconi S.I., Andrei S., Valeanu L., Stefan M.-G., Grigoras I., Copotoiu S., Bodolea C., Tomescu D., Popescu M., Filipescu D., et al.
Journal: European Journal of Anaesthesiology
Year: 2023


📄 Cervico-Thoracic Air Collections in COVID-19 Pneumonia Patients – Our Experience and Brief Review
Authors: C.E. Nistor, C.S. Gavan, D. Pantile, N.V. Tănase, A. Ciuche
Journal: Chirurgia (Romania)
Year: 2022


📄 Individualized Surgical Antibiotic Prophylaxis – Why, When, and How?
Authors: Dan Corneci, Ligia I. Torsin, Cristina R. Filimon, Narcis V. Tănase, Emanuel Moisa, Silvius I. Negoita
Journal: Romanian Journal of Military Medicine
Year: 2022


Theodoros Grivas | Medicine and Dentistry | Lifetime Achievement Award

Dr. Theodoros Grivas | Medicine and Dentistry | Lifetime Achievement Award

Tzaneio General Hospital of Piraeus | Greece 

Aurhor Profile

Scopus

Orcid

Google Scholar

🎓 Early Academic Pursuits

Dr. Theodoros B. Grivas began his illustrious journey in medicine by graduating from the Medical School at “Aristotle” University of Thessaloniki in 1978. His academic foundation was further solidified through comprehensive training in General Surgery, Paediatric and Adult Orthopaedics, and Traumatology in Greece. Driven by a passion for deepening his expertise, he pursued and earned a Ph.D. from the National and Kapodistrian University of Athens, establishing a robust foundation for his future contributions to orthopaedic and spinal surgery.

💼 Professional Endeavors

Throughout his career, Dr. Grivas worked at prestigious institutions, including the “University Hospital” at Queen’s Medical Centre in Nottingham, “Harlow Wood” Orthopaedic Hospital in Mansfield, UK, and prominent hospitals in Athens, Greece. Notably, he served as the Director of the Orthopaedics and Traumatology Department at “Thriasio” Hospital for five years and later at “Tzaneio” General Hospital of Piraeus for 12 years until his retirement in 2021. His leadership and expertise significantly impacted the field, where he played a pivotal role in advancing patient care and surgical practices.

🔬 Contributions and Research Focus

Dr. Grivas has an impressive record of scientific contributions, including over 645 scientific publications and presentations, with 136 indexed in Medline. His research spans various orthopaedic and spinal topics, with a particular focus on school screening programs and spinal deformities. As a principal investigator or collaborator, he was involved in 20 research projects, funded by national and European sources. Additionally, he established a National Training Center for school-screening examiners and was a key figure in implementing the School Screening program in Greece.

🏆 Accolades and Recognition

Dr. Grivas’s achievements have been recognized both nationally and internationally. He has served as a member and Traveling Fellow of renowned organizations like AAOS, AOA, and SRS. He held the presidency of the IRSSD, SOSORT (which he helped found), and the Hellenic Spine Society. His editorial contributions include serving as the Chief Editor of the BMC open access journal “Scoliosis and Spinal Deformities,” and as a member of the editorial board or a reviewer for several peer-reviewed journals. His department was also honored with the opportunity to provide the “Trialect platform” Fellowship in Orthopaedics and Traumatology.

🌍 Impact and Influence

Dr. Grivas’s influence extends beyond his immediate clinical work, impacting the broader medical community through his involvement in critical decision-making bodies. During 2019-2020, he served on the National Examination Committee for Orthopaedics and Traumatology and was a member of the Crisis and Selection Council of the Hellenic National Health System from 2020-2021, which is responsible for the appointment of Orthopaedic Surgeons in State Hospital Positions.

🚀 Legacy and Future Contributions

Even in retirement, Dr. Grivas continues to contribute to the field he has dedicated his life to. He is currently focused on establishing the Hellenic Scoliosis Foundation, aiming to further advance the understanding and treatment of scoliosis. His enduring legacy lies in his vast body of work, the numerous professionals he has mentored, and the patients whose lives he has improved through his expertise in orthopaedics and spinal surgery. His future contributions promise to leave a lasting impact on the field, continuing to inspire and guide the next generation of surgeons.

 

Publications


📄 Rib index is a strong surrogate of scoliometric reading in idiopathic scoliosis
Author(s): Grivas, T.B., Jevtic, N., Ljubojevic, D., Mamzari, A., Vasiliadis, E.
Journal: European Spine Journal
Year: 2024


📄 Cross-cultural adaptation, reliability and validity of the Greek version of the Spinal Appearance Questionnaire (SAQ) in patients with adolescent idiopathic scoliosis
Author(s): Oikonomaki, M., Kelalis, G., Skouras, A.Z., Georgoudis, G., Grivas, T.
Journal: Spine Deformity
Year: 2024


📄 A Questionnaire of Physiotherapeutic Specific Exercises of Scoliosis—QPSSE
Author(s): Grivas, T.B., Dadakaridou, D., Fokidi, S.A., Theodosopoulos, E., Griva, A.M.
Journal: Journal of Clinical Medicine
Year: 2024


📄 Menarche in Scoliotic and Non-Scoliotic Balkan Girls and the Relationship between Menarche and the Laterality of Scoliotic Curves
Author(s): Pjanic, S., Jevtic, N., Grivas, T.B.
Journal: Journal of Clinical Medicine
Year: 2024


📄 Segmental Rib Index and Spinal Deformity: Scoliogenic Implications
Author(s): Grivas, T.B., Jevtic, N., Ljubojevic, D., Golic, F., Vasiliadis, E.
Journal: Healthcare (Switzerland)
Year: 2023


 

Christian Pfister | Medicine and Dentistry | Excellence in Research Award

Prof. Christian Pfister | Medicine and Dentistry | Excellence in Research Award

Rouen University Hospital | France

Author Profile

Scopus

Early Academic Pursuits

Prof. Christian Pfister's academic journey commenced with a focus on urology at Charles Nicolle University Hospital in Rouen, France. His early academic pursuits involved comprehensive studies in urological sciences, laying the foundation for a distinguished career in the medical field.

Professional Endeavors

Having established himself as a prominent figure in the field of urology, Prof. Christian Pfister has been associated with the Rouen University Hospital in France. His professional endeavors encompass a wide array of responsibilities within the Department of Urology, where he contributes to patient care, education, and research initiatives.

Contributions and Research Focus

Prof. Pfister's contributions extend beyond clinical practice, with a significant focus on urological research. His research endeavors likely involve advancements in urological treatments, surgical techniques, and potentially groundbreaking discoveries that contribute to the broader medical community's knowledge and understanding.

Accolades and Recognition

Prof. Christian Pfister has likely received accolades and recognition for his outstanding contributions to urology. Recognition may come in the form of awards, honors, or appointments to leadership positions within medical societies, acknowledging his expertise and impact on the field.

Impact and Influence

Prof. Pfister's impact is evident in his influence on the practice of urology, both locally within Rouen University Hospital and potentially on a broader scale. Through his clinical expertise, research contributions, and potential leadership roles, he likely plays a pivotal part in shaping urological practices and advancements.

Legacy and Future Contributions

As a seasoned professional in the field, Prof. Christian Pfister is likely building a lasting legacy in urology. His current contributions, coupled with his dedication to education and patient care, suggest a commitment to leaving a lasting impact on the field. His future contributions may involve mentoring the next generation of urologists and further advancing urological knowledge and treatments.

Notable Publications

Perioperative dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin in muscle-invasive bladder cancer (VESPER): survival endpoints at 5 years in an open-label, randomised, phase 3 study  2023 (1)

Differential impact of COVID-19 on urological surgeries in public and private institutions between 2019 and 2021 in France | Impact du COVID-19 sur l'activité chirurgicale urologique dans les établissements de santé publics et privés entre 2019 et 2021 en France 2023 (1)

Refining the Characterization and Outcome of Pathological Complete Responders after Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer: Lessons from the Randomized Phase III VESPER (GETUG-AFU V05) Trial 2023 (4)

Testicular recurrence of oligometastatic prostatic adenocarcinoma after 22 years of androgen deprivation therapy  2022 (1)